Losartan Medicare Part D Coverage: Formulary Status, Costs, and Savings in 2026

Why Medicare Part D Covers Losartan at Preferred Tiers

Losartan potassium, first approved by the FDA in 1995 as Cozaar, is an angiotensin II receptor blocker (ARB) prescribed for hypertension, diabetic nephropathy in patients with type 2 diabetes, and stroke risk reduction in patients with left ventricular hypertrophy [1]. After Merck's patent expired in 2010, multiple generic manufacturers entered the market, driving the average cash price below $15 for a 30-day supply [2].

How Part D Formulary Tiers Work

Medicare Part D plans organize drugs into tiers. Tier 1 carries the lowest copay and is reserved for widely used, cost-effective generics. Because losartan meets every criterion (strong evidence base, low acquisition cost, broad guideline support), the Centers for Medicare & Medicaid Services (CMS) classifies ARBs as a protected class, meaning Part D plans must cover substantially all ARBs on their formularies [3]. Generic losartan almost always lands on Tier 1 or Tier 2, which translates to copays of $0 to $15 depending on the specific plan [4].

CMS Protected-Class Rules for ARBs

The CMS protected-class designation for renin-angiotensin system agents prevents Part D sponsors from using aggressive prior authorization or step therapy to restrict access [3]. This policy traces back to the Medicare Modernization Act of 2003 and subsequent CMS guidance. In practice, it means a beneficiary switching from an ACE inhibitor to losartan due to cough (a well-documented ACE-inhibitor side effect occurring in 5% to 35% of patients) can fill the prescription without prior authorization hurdles [5].

What You Will Pay Out of Pocket in 2026

The Inflation Reduction Act (IRA) restructured Medicare Part D cost-sharing beginning in 2025, capping total annual out-of-pocket spending at $2,000 [6]. For a drug as inexpensive as generic losartan, most beneficiaries will never approach that threshold from this medication alone.

Monthly Cost Breakdown by Plan Phase

During the deductible phase (which some Part D plans waive for Tier 1 generics), a beneficiary pays the full negotiated price. For losartan 50 mg, that negotiated price is typically $3 to $12 [2]. After the deductible, the standard copay applies. A 2024 CMS analysis found that the median Tier 1 copay across all Part D plans was $2 for preferred generics [4]. With the $2,000 hard cap now in effect, even beneficiaries taking multiple branded medications gain predictable total exposure [6].

The Medicare Prescription Payment Plan

Starting in 2025, CMS introduced the Medicare Prescription Payment Plan, allowing beneficiaries to spread out-of-pocket costs across monthly installments rather than paying large sums at the pharmacy counter [7]. While losartan itself is unlikely to trigger high point-of-sale costs, beneficiaries taking losartan alongside expensive branded drugs (GLP-1 agonists, PCSK9 inhibitors) benefit from smoothed monthly payments across their entire drug regimen.

How to Verify Losartan Coverage on Your Specific Plan

Not all Part D plans price losartan identically. Tier placement, copay amount, and preferred pharmacy networks vary by plan sponsor and region.

Using the Medicare Plan Finder

The most reliable verification method is the Medicare Plan Finder at medicare.gov. Enter your zip code, select your current plan (or compare new plans), and search for "losartan potassium" in the formulary tool [8]. The tool displays the tier, copay or coinsurance, any quantity limits, and whether your pharmacy is in-network. CMS updates this database quarterly.

Checking for Quantity Limits and Step Therapy

Some Part D plans impose quantity limits on losartan (commonly 30 or 90 tablets per fill). Step therapy requirements are rare for generic losartan but may exist in plans that prefer a different generic ARB, such as valsartan, as their Tier 1 option [3]. If your plan requires step therapy, your prescriber can submit a formulary exception request. CMS regulations require plans to respond to standard exception requests within 72 hours [8].

Preferred Pharmacy Networks

Many Part D plans offer lower copays ($0 in some cases) when you fill at a preferred pharmacy. Large chains, mail-order pharmacies, and some independent pharmacies participate in these networks. For losartan specifically, the cost difference between preferred and non-preferred pharmacies can be $5 to $10 per fill [4]. Confirm your pharmacy's network status through the Plan Finder or by calling the number on your Part D membership card.

Clinical Evidence Supporting Losartan Use

Medicare coverage decisions are grounded in clinical evidence. Losartan's formulary position reflects decades of trial data across multiple cardiovascular and renal endpoints.

The LIFE Trial: Stroke Prevention

The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) trial randomized 9,193 patients with hypertension and left ventricular hypertrophy to losartan-based or atenolol-based therapy [9]. Over a mean follow-up of 4.8 years, losartan reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% (p=0.021), driven primarily by a 25% relative risk reduction in stroke [9]. This trial earned losartan its FDA indication for stroke risk reduction in hypertensive patients with LVH.

The RENAAL Trial: Diabetic Nephropathy

The Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial enrolled 1,513 patients with type 2 diabetes and nephropathy [10]. Losartan 50 to 100 mg daily reduced the risk of doubling of serum creatinine by 25% (p=0.006) and the risk of end-stage renal disease by 28% (p=0.002) compared with placebo, both on top of conventional antihypertensive therapy [10]. The trial established ARBs as a standard-of-care for diabetic kidney disease.

ACC/AHA Guideline Positioning

The 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults recommends ACE inhibitors or ARBs as first-line therapy for patients with hypertension and comorbid diabetes, chronic kidney disease, or heart failure [11]. For beneficiaries with these conditions, losartan is not just covered by Part D. It is guideline-recommended as an initial treatment choice.

Extra Help and Low-Income Subsidy Programs

Medicare Extra Help (the Low-Income Subsidy, or LIS) significantly reduces Part D costs for qualifying beneficiaries.

Eligibility Thresholds

In 2026, full Extra Help is available to individuals with annual incomes below 150% of the federal poverty level and limited resources [12]. Partial Extra Help covers those with slightly higher incomes. Full Extra Help beneficiaries pay $0 for generics in 2026, while partial Extra Help limits generic copays to approximately $4.50 [12].

How to Apply

Applications go through the Social Security Administration (SSA) at ssa.gov or by calling 1-800-772-1213. State Health Insurance Assistance Programs (SHIPs) provide free counseling to help beneficiaries determine eligibility and complete the application [8]. Processing typically takes 2 to 4 weeks.

Impact on Losartan Costs

For a beneficiary paying $8 per month for losartan under standard Part D, Extra Help enrollment drops the cost to $0 to $4.50. Over 12 months, that savings totals $42 to $96 annually. While the absolute savings on losartan alone are modest, Extra Help applies to every Part D medication, so beneficiaries on multiple drugs see compounding benefits.

Additional Savings Strategies Beyond Part D

Even with Part D coverage, several strategies can lower losartan costs further or help uninsured individuals access the drug affordably.

Pharmacy Discount Programs

Major pharmacy chains offer generic drug discount programs that sometimes undercut Part D copays. Walmart, Costco, and several grocery-chain pharmacies include losartan on $4-per-month generic lists [2]. If your Part D copay exceeds $4, paying the cash discount price (which does not count toward your Part D deductible or out-of-pocket cap) may save money in the short term, though it sacrifices progress toward the $2,000 annual cap [6].

90-Day Mail-Order Fills

Most Part D plans offer 90-day supplies through mail-order pharmacies at reduced per-unit costs. A typical 90-day copay for a Tier 1 generic is $0 to $10 total, compared with $0 to $15 for three separate 30-day fills [4]. Mail-order also reduces pharmacy trips, which matters for beneficiaries with mobility limitations.

State Pharmaceutical Assistance Programs

Approximately 20 states operate State Pharmaceutical Assistance Programs (SPAPs) that supplement Part D coverage [13]. These programs may cover Part D premiums, deductibles, or copays. Eligibility criteria vary by state. The Medicare website maintains a directory of SPAPs searchable by state [8].

GoodRx and Manufacturer Programs

Third-party discount cards like GoodRx frequently list losartan 50 mg at $3 to $8 for a 30-day supply [2]. Merck no longer offers a branded Cozaar copay card (the brand has minimal market share), but generic manufacturers do not typically run copay programs for drugs this inexpensive. The practical approach: compare your Part D copay against the GoodRx or pharmacy discount price and use whichever is lower.

Losartan Dosing and Formulations Covered by Part D

Understanding which formulations Part D covers helps prevent surprise costs at the pharmacy.

Available Strengths

Generic losartan potassium is available in 25 mg, 50 mg, and 100 mg tablets [1]. All three strengths are covered under the same tier on Part D formularies. The starting dose for hypertension is typically 50 mg once daily, with titration to 100 mg if blood pressure remains uncontrolled [11]. For patients who are volume-depleted (on diuretics, for example), a 25 mg starting dose is recommended [1].

Losartan-Hydrochlorothiazide Combination

The fixed-dose combination of losartan 50 mg/hydrochlorothiazide (HCTZ) 12.5 mg and losartan 100 mg/HCTZ 25 mg is also available as a generic [1]. Most Part D plans cover losartan/HCTZ at Tier 1 or Tier 2 as well. The combination tablet simplifies regimens for patients requiring both an ARB and a thiazide diuretic, which is a common pairing supported by JNC and ACC/AHA guidelines [11].

Brand Cozaar vs. Generic

If a prescriber writes for brand-name Cozaar, Part D plans may place it on Tier 3 (preferred brand) or higher, with copays of $30 to $80. Because the generic is therapeutically equivalent (FDA "AB" rated), there is no clinical reason to pay more for the brand [14]. If your pharmacy dispenses the brand, ask your pharmacist or prescriber to authorize generic substitution.

Switching From Other Antihypertensives Under Part D

Beneficiaries sometimes need to switch medications due to side effects, efficacy, or formulary changes during Part D open enrollment.

ACE Inhibitor to Losartan

Dry cough affects an estimated 5% to 35% of patients taking ACE inhibitors such as lisinopril or enalapril [5]. Switching to losartan eliminates this side effect because ARBs do not increase bradykinin levels. The ACC/AHA guidelines support ARBs as an alternative first-line option when ACE inhibitors are not tolerated [11]. No dose taper is needed; patients can start losartan the day after discontinuing the ACE inhibitor.

Other ARBs to Losartan

Part D formulary changes during the Annual Election Period (October 15 to December 7) may shift preferred ARB status. If your plan moves valsartan or irbesartan to a higher tier, switching to losartan (if it remains Tier 1) avoids increased copays. An 8 mg candesartan dose is roughly equivalent to 50 mg losartan, while 80 mg valsartan corresponds to approximately 50 mg losartan [15]. Your prescriber can adjust the dose based on published ARB equivalence data and blood pressure response.

Monitoring Requirements and Part D Preventive Benefits

Losartan requires periodic lab monitoring. Medicare Part B (not Part D) covers many of these labs at no additional cost.

Recommended Lab Tests

The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend checking serum creatinine, estimated GFR, and serum potassium within 2 to 4 weeks of starting or uptitrating an ARB, then at least annually [16]. Medicare Part B covers basic metabolic panels when ordered for a medically necessary reason, which blood pressure management qualifies as [8]. Patients with diabetic nephropathy may need more frequent monitoring per KDIGO recommendations: every 3 to 6 months [16].

Blood Pressure Monitoring Coverage

Medicare Part B covers home blood pressure monitors when prescribed for a diagnosed hypertension condition. A 2023 AHA scientific statement endorsed home blood pressure monitoring as a component of effective hypertension management [17]. Combined with losartan therapy, home monitoring helps beneficiaries and clinicians track treatment response between office visits.

Part D Annual Enrollment: When and How to Review Losartan Coverage

Part D coverage terms can change every plan year. An annual review ensures losartan remains on the most cost-effective plan.

Key Enrollment Dates

The Annual Election Period runs October 15 through December 7 each year. Changes take effect January 1 [8]. The Medicare Open Enrollment Period (January 1 to March 31) allows one additional plan switch. Beneficiaries should compare losartan tier placement, copay amounts, and preferred pharmacy networks across available plans using the Medicare Plan Finder.

What to Check Each Year

Verify three things: (1) that losartan potassium remains on Tier 1, (2) that your pharmacy is still in the preferred network, and (3) that any other medications you take are also on favorable tiers. A plan that saves $3 on losartan but charges $50 more for another medication is a net loss. CMS publishes updated formularies for all Part D plans by October 1 each year [8].

Beneficiaries already taking losartan 50 mg or 100 mg daily should confirm their 2026 plan details at medicare.gov and contact their State Health Insurance Assistance Program at 1-877-839-2675 if they need help comparing options [8].